68.1 F
San Diego
Tuesday, Jul 23, 2024

QuidelOrtho CEO Excels at Overcoming Challenges

DIAGNOSTICS: Acquisitions, Pandemic Scale Up Highlight Bryant’s Tenure

Douglas Bryant has served as president and CEO of Quidel Corporation since 2009, leading the company through its most transformative years, including its stellar response to the COVID-19 pandemic and through last year’s acquisition of Ortho Clinical Diagnostics that ushered in the company’s next phase of innovation as QuidelOrtho.

San Diego Business Journal has named Bryant CEO of the Year in the Large Company Category.

Career of Successes

Bryant has more than 30 years of leadership experience in the diagnostics industry. Before joining Quidel in 2009, he served as executive vice president and chief operating officer at Luminex Corporation. Prior to that, he held various worldwide commercial operations positions with Abbott Laboratories.

Douglas Bryant

Bryant’s leadership has been cited by peers and pundits in the medtech space as a key driver of Quidel’s success over the years. Among Bryant’s successes, he oversaw the acquisition of Abbott’s Triage business in 2017, which led to a doubling of Quidel’s revenue.

In 2020, faced with the worldwide COVID pandemic, Bryant directed and led Quidel to meet the challenge, bringing to market a PCR test and then a rapid antigen test to detect SARS-CoV-2 – the world’s first to receive FDA Emergency Use Authorization. To meet demand and despite supply chain issues, Bryant scaled up production from a capacity of approximately 100 million tests per year to nearly 1 billion.

Quidel’s quick-to-market and quick-to-scale tests rewarded the company with a six-fold increase in revenue from 2019 to 2022 – from $535.5 million to $3 billion.

Bryant’s most recent milestone is the May 2022 successful acquisition of Ortho Clinical Diagnostics to form QuidelOrtho, which added large-scale diagnostic testing capabilities to the company. For this next phase of the company, Bryant has set a course for the future, with plans to extend QuidelOrtho’s impact to help decentralize and democratize access to testing.

In the year since the acquisition, QuidelOrtho moved with speed to integrate the companies while keeping focus on employees, minimizing customer disruption and maintaining high levels of service. This allowed the company to drive record revenue quarters, preserve more than 85% of its employee base and complete more than 80% of the integration activities.

Leading Community Engagement

Currently, Bryant leads a team of approximately 7,000, which he does by promoting a “can-do” attitude.

“People who are happy tend to be more productive, and people who are more productive have better outcomes, which in turn makes them happy,” he explains. “It’s a circular thing. So that at our company, we have a bunch of people who are just genuinely happy and productive.”

One of Bryant’s goals at QuidelOrtho is to encourage employees to engage with the community. QuidelOrtho actively participates in holiday toy drives; supports the American Heart Association to advance education and awareness of heart disease; sponsors community blood drives; and funds research initiatives at San Diego State University’s newly formed Research Corridor. That is on top of the company’s programs to provide free COVID-19 tests to high-risk communities and its local Safe at Home program providing tests outside Petco Park.

Bryant has also led QuidelOrtho’s commitment to environmental sustainability, which includes monitoring the impacts of waste generation and energy and water consumption and implementing efficiencies at its global facilities and in product manufacturing that mitigate risks, reduce costs and address impacts.


“From our response to the pandemic to our business combination to become QuidelOrtho, we’re creating a truly transformational global diagnostics company powered by a vibrant workplace culture, enduring customer relationships and a commitment to developing life-changing technologies at speed. On behalf of all our dedicated employees making an impact in our San Diego community and around the world, I’m honored to be selected as a winner of the SDBJ CEO of the Year award. As we continue to deepen our company culture and advance our diagnostic innovations, I look forward to expanding our services to laboratories and clinicians across the healthcare continuum and enabling improved health outcomes for patients.”


Featured Articles


Related Articles